UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

Oncogene, 2007-11, Vol.26 (50), p.7158-7162

2007

Volltextzugriff (PDF)

Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse

Differentiation (London), 2017-03, Vol.94, p.8-20

2017

Volltextzugriff (PDF)

High frequency of BRAF mutations in nevi

Nature genetics, 2003-01, Vol.33 (1), p.19-20

2003

Volltextzugriff (PDF)

The CDKN2A (p16) gene and human cancer

Molecular medicine (Cambridge, Mass.), 1997-01, Vol.3 (1), p.5-20

1997

Volltextzugriff (PDF)

CDKN2A/p16 is inactivated in most melanoma cell lines

Cancer research (Chicago, Ill.), 1997-11, Vol.57 (21), p.4868-4875

1997

Volltextzugriff (PDF)

Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines

Melanoma research, 2002-04, Vol.12 (2), p.183-186

2002

Volltextzugriff (PDF)

The genetics of cutaneous melanoma

Clinics in laboratory medicine, 2000-12, Vol.20 (4), p.667-690

2000

Volltextzugriff (PDF)

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines

Melanoma research, 2002-12, Vol.12 (6), p.565-575

2002

Volltextzugriff (PDF)

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

Oncogene, 1997-12, Vol.15 (24), p.2999-3005

1997

Volltextzugriff (PDF)

CDKN2A mutation in a non‐FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein

International journal of cancer, 1997-11, Vol.73 (4), p.531-536

1997

Volltextzugriff (PDF)

Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (3), p.1154-1161

2001

Volltextzugriff (PDF)

XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts

Anti-cancer drugs, 2013-02, Vol.24 (2), p.181-188

2013

Volltextzugriff (PDF)

Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions

Genes chromosomes & cancer, 1996-02, Vol.15 (2), p.77-88

1996

Volltextzugriff (PDF)

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines

Oncogene, 1995-08, Vol.11 (4), p.663-668

1995

Volltextzugriff (PDF)

Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (14), p.6282-6293

2005

Volltextzugriff (PDF)

A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding

American journal of human genetics, 2016-06, Vol.98 (6), p.1159-1169

2016

Volltextzugriff (PDF)

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations

Human mutation, 1998, Vol.11 (6), p.424-431

1998

Volltextzugriff (PDF)

A genome-based strategy uncovers frequent BRAF mutations in melanoma

Cancer Cell, 2002-07, Vol.2 (1), p.5-7

2002

Volltextzugriff (PDF)

Mutation analysis of the CDKN2A promoter in Australian melanoma families

Genes chromosomes & cancer, 2001-09, Vol.32 (1), p.89-94

2001

Volltextzugriff (PDF)

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Oncogene, 2004-05, Vol.23 (23), p.4060-4067

2004

Volltextzugriff (PDF)

CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin

International journal of cancer, 2001-08, Vol.93 (3), p.361-367

2001

Volltextzugriff (PDF)

p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

Molecular cancer therapeutics, 2004-08, Vol.3 (8), p.895-902

2004

Volltextzugriff (PDF)

Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk

Human reproduction (Oxford), 2008-07, Vol.23 (7), p.1661-1668

2008

Volltextzugriff (PDF)

1 – 25 von 2.222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.002)
Mit Volltextzugriff
(1.844)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.477)
Life Sciences & Biomedicine
(1.020)
Humans
(799)
Female
(464)
Male
(454)
Biological And Medical Sciences
(412)
Medical Sciences
(325)
Physical Sciences
(307)
Animals
(280)
Middle Aged
(268)
Adult
(245)
Aged
(233)
Physics
(181)
Technology
(145)
Astronomy & Astrophysics
(131)
Surgery
(128)
Materials Science
(116)
Adolescent
(114)
Neurosciences & Neurology
(109)
Fundamental And Applied Biological Sciences. Psychology
(106)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Geophysical Research Letters
(49)
The Astrophysical Journal
(39)
Acta Materialia
(38)
Bmj
(33)
Physical Review Letters
(33)
Journal Of Geophysical Research. Space Physics
(29)
Astronomy And Astrophysics
(27)
Neurosurgery
(25)
British Medical Journal
(24)
Bmj. British Medical Journal
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse

High frequency of BRAF mutations in nevi

The CDKN2A (p16) gene and human cancer

CDKN2A/p16 is inactivated in most melanoma cell lines

Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines

The genetics of cutaneous melanoma

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

CDKN2A mutation in a non‐FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein

Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development

XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts

Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines

Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells

A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations

A genome-based strategy uncovers frequent BRAF mutations in melanoma

Mutation analysis of the CDKN2A promoter in Australian melanoma families

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia

Microarray expression profiling in melanoma reveals a BRAF mutation signature

CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin

p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas

Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk

Suchergebnisse filtern